Your search for ‘Ogilvy Renault’ returned 192 results

On August 17, 2009, Justice Mark G. Peacock of the Quebec Superior Court ruled in favour of the respondent GlaxoSmithKline Inc. (GSK), represented by Ogilvy Renault, dismissing a Motion for Authorization to Institute a Class Action (the "Motion for Authorization") made by the petitioner on behalf of all persons residing in Canada who have experienced dependency and withdrawal problems owing to the use of the antidepressant medication marketed under the name PAXIL.

A look at industry shows that Canadian financial institutions are not fully committed to the protection of their innovations. and technology through the filing of patent applications.